ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NBY NovaBay Pharmaceuticals Inc New

3.06
0.23 (8.13%)
Jun 06 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.63M3.05M5.09M3.64M3.12M4.61M3.27M3.73M
Operating Income -2.38M-2.15M-457k-9.43M-1.73M-1.36M-1.12M-3.39M
Pre Tax Income -111k-2.16M-136k-8.21M-1.74M-2.04M-1.76M-4.11M
Net Income -111k-2.16M-5.79M-8.21M-1.74M-4.03M-1.76M-9.17M
Preferred Dividends 000-5.66M0-2M0-7.06M
Basic Earnings Per Share (EPS) 00000000
EBIT -2.39M-1.94M-628k-9.52M-1.74M-2.29M-1.47M-4.16M
EBITDA -2.26M-2.03M-338k-2.57M-1.68M-1.3M-1.07M-748k
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 11.9M18.23M12.51M6.6M9.93M8.42M14.4M14.73M
Operating Income -10.98M-7.31M-7.87M-9.4M-6.43M-8.86M-14.42M-7.6M
Pre Tax Income -13.15M-7.4M-6.54M-9.65M-11.03M-5.82M-10.61M-9.64M
Net Income -13.15M-7.4M-6.55M-10.46M-11.04M-6.56M-16.27M-16.7M
Preferred Dividends 000-800k0-735k-5.66M-7.06M
Basic Earnings Per Share (EPS) -0.861-0.481-0.383-0.374-0.264-0.137-0.25-2.557
EBIT -11.05M-7.3M-7.85M-10.83M-5.82M-10.44M-14.69M-9.66M
EBITDA -10.87M-7.22M-7.61M-9.34M-6.38M-8.8M-7.2M-4.8M

Your Recent History

Delayed Upgrade Clock